This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

NASH and fibrosis progression

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Fibrosis Progression in NASH

Approximately 40% of NASH patients progress to fibrosis globally (1,2)

  • 5% and 10% of patients with NASH diagnosed on their initial biopsy will present with clinically significant fibrosis at this initial biopsy, and an additional 15-20% will progress to advanced fibrosis in less than a decade (2)
  • age and presence of inflammation on initial biopsy are independent predictors of progression to advanced fibrosis (3)

Reference:

  1. Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L,Wymer M. Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology.2016;64(1):73-84
  2. Argo C, Northup P, Al-Osaimi A, Caldwell S. Systematic review of risk factors for fibrosis progressionin non-alcoholic steatohepatitis. J Hepatol. 2009;51(2):371-9.
  3. Hashimoto E, Tokushige K. Prevalence, gender,ethnic variations, and prognosis of NASH. J Gastroenterol. 2011;46(suppl 1):63–9.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.